SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : John, Mike & Tom's Wild World of Stocks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Pitera who wrote (1180)6/1/2000 6:51:00 PM
From: Logain Ablar  Read Replies (1) of 2850
 
I just see the 8 million women taking progestin and
estrogen have a much greater chance of getting breast
cancer

We'll if you want to look at an inexpensive company (stock) that recently received approval for generic estrogen and Merck/Medco added the pill to their recomended list check out DRMD. Warning it won't jump 60% like the super conductor stocks.

Does have the potential to double from here as sales just started ramping in April (gleamed from the cc).

Tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News